BPC-157 is not registered as a drug in the EU or USA (clinical development PL 14736 halted at phase II in 2014) and has been on the WADA Prohibited List since 2022 in category S0 (non-approved substances)
However, in some cases, it may be prescribed off-label as part of a weight loss plan for patients
CJC1295 increases GH release through GHRH pathways, while Ipamorelin stimulates GH through GHRP (ghrelin) receptors
The Food and Drug Administration is asking Eli Lilly to gather more safety data on its new weight loss pill, Foundayo, including whether it could be linked to liver and heart problems, according to the approval letter published online Tuesday
PMID: 33247860 14 Unpleasant Smell: A Case Report of Trimethylaminuria (Fish Odour Syndrome) in a Child
However, the market response was unexpected: Lillys stock plummeted 14% that day, erasing approximately $100 billion in market value